Global Immune Thrombocytopenic Purpura Therapeutics Market Research Report 2019

Table of Contents

Executive Summary

1 Immune Thrombocytopenic Purpura Therapeutics Market Overview

• 1.1 Product Overview and Scope of Immune Thrombocytopenic Purpura Therapeutics
• 1.2 Immune Thrombocytopenic Purpura Therapeutics Segment by Type
  • 1.2.1 Global Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Eltrombopag Olamine
  • 1.2.3 Fostamatinib Disodium
  • 1.2.4 GL-2045
  • 1.2.5 Avatrombopag
  • 1.2.6 BI-655064
  • 1.2.7 Others
• 1.3 Immune Thrombocytopenic Purpura Therapeutics Segment by Application
  • 1.3.1 Immune Thrombocytopenic Purpura Therapeutics Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.3 Global Immune Thrombocytopenic Purpura Therapeutics Market by Region
  • 1.3.1 Global Immune Thrombocytopenic Purpura Therapeutics Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Immune Thrombocytopenic Purpura Therapeutics Market Size
  • 1.4.1 Global Immune Thrombocytopenic Purpura Therapeutics Revenue (2014-2025)
  • 1.4.2 Global Immune Thrombocytopenic Purpura Therapeutics Production (2014-2025)

2 Global Immune Thrombocytopenic Purpura Therapeutics Market Competition by Manufacturers

• 2.1 Global Immune Thrombocytopenic Purpura Therapeutics Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Immune Thrombocytopenic Purpura Therapeutics Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Immune Thrombocytopenic Purpura Therapeutics Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Immune Thrombocytopenic Purpura Therapeutics Production Sites, Area Served, Product Types
• 2.5 Immune Thrombocytopenic Purpura Therapeutics Market Competitive Situation and Trends
  • 2.5.1 Immune Thrombocytopenic Purpura Therapeutics Market Concentration Rate
  • 2.5.2 Immune Thrombocytopenic Purpura Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Immune Thrombocytopenic Purpura Therapeutics Production Market Share by Regions

• 3.1 Global Immune Thrombocytopenic Purpura Therapeutics Production Market Share by Regions
• 3.2 Global Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share by Regions (2014-2019)
• 3.3 Global Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Immune Thrombocytopenic Purpura Therapeutics Production
  • 3.4.1 North America Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate (2014-2019)
  • 3.4.2 North America Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Immune Thrombocytopenic Purpura Therapeutics Production
  • 3.5.1 Europe Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate (2014-2019)
  • 3.5.2 Europe Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Immune Thrombocytopenic Purpura Therapeutics Production (2014-2019)
  • 3.6.1 China Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate (2014-2019)
  • 3.6.2 China Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Immune Thrombocytopenic Purpura Therapeutics Production (2014-2019)
  • 3.7.1 Japan Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate (2014-2019)
  • 3.7.2 Japan Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Immune Thrombocytopenic Purpura Therapeutics Consumption by Regions

• 4.1 Global Immune Thrombocytopenic Purpura Therapeutics Consumption by Regions
• 4.2 North America Immune Thrombocytopenic Purpura Therapeutics Consumption (2014-2019)
• 4.3 Europe Immune Thrombocytopenic Purpura Therapeutics Consumption (2014-2019)
• 4.4 China Immune Thrombocytopenic Purpura Therapeutics Consumption (2014-2019)
• 4.5 Japan Immune Thrombocytopenic Purpura Therapeutics Consumption (2014-2019)

5 Global Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price Trend by Type

• 5.1 Global Immune Thrombocytopenic Purpura Therapeutics Production Market Share by Type (2014-2019)
• 5.2 Global Immune Thrombocytopenic Purpura Therapeutics Revenue Market Share by Type (2014-2019)
• 5.3 Global Immune Thrombocytopenic Purpura Therapeutics Price by Type (2014-2019)
• 5.4 Global Immune Thrombocytopenic Purpura Therapeutics Production Growth by Type (2014-2019)

6 Global Immune Thrombocytopenic Purpura Therapeutics Market Analysis by Applications

• 6.1 Global Immune Thrombocytopenic Purpura Therapeutics Consumption Market Share by Application (2014-2019)
• 6.2 Global Immune Thrombocytopenic Purpura Therapeutics Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Immune Thrombocytopenic Purpura Therapeutics Business

• 7.1 Amgen Inc.
  • 7.1.1 Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 7.1.2 Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
  • 7.1.3 Amgen Inc. Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Baxalta Incorporated
  • 7.2.1 Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 7.2.2 Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
  • 7.2.3 Baxalta Incorporated Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Boehringer Ingelheim GmbH
  • 7.3.1 Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 7.3.2 Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
  • 7.3.3 Boehringer Ingelheim GmbH Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Bristol-Myers Squibb Company
  • 7.4.1 Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 7.4.2 Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
  • 7.4.3 Bristol-Myers Squibb Company Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Eisai
  • 7.5.1 Eisai Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 7.5.2 Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
  • 7.5.3 Eisai Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Hansa Medical AB
  • 7.6.1 Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 7.6.2 Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
  • 7.6.3 Hansa Medical AB Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Immunomedics, Inc.
  • 7.7.1 Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 7.7.2 Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
  • 7.7.3 Immunomedics, Inc. Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Intas Pharmaceuticals Ltd.
  • 7.8.1 Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 7.8.2 Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
  • 7.8.3 Intas Pharmaceuticals Ltd. Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Jiangsu Hengrui Medicine Co., Ltd.
  • 7.9.1 Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 7.9.2 Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
  • 7.9.3 Jiangsu Hengrui Medicine Co., Ltd. Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Merck & Co., Inc.
  • 7.10.1 Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Production Sites and Area Served
  • 7.10.2 Immune Thrombocytopenic Purpura Therapeutics Product Introduction, Application and Specification
  • 7.10.3 Merck & Co., Inc. Immune Thrombocytopenic Purpura Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Momenta Pharmaceuticals, Inc.
• 7.12 Novartis AG
• 7.13 Pfizer Inc.

8 Immune Thrombocytopenic Purpura Therapeutics Manufacturing Cost Analysis

• 8.1 Immune Thrombocytopenic Purpura Therapeutics Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Immune Thrombocytopenic Purpura Therapeutics
• 8.4 Immune Thrombocytopenic Purpura Therapeutics Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Immune Thrombocytopenic Purpura Therapeutics Distributors List
• 9.3 Immune Thrombocytopenic Purpura Therapeutics Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Immune Thrombocytopenic Purpura Therapeutics Market Forecast

• 11.1 Global Immune Thrombocytopenic Purpura Therapeutics Production, Revenue Forecast
  • 11.1.1 Global Immune Thrombocytopenic Purpura Therapeutics Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Immune Thrombocytopenic Purpura Therapeutics Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Immune Thrombocytopenic Purpura Therapeutics Price and Trend Forecast (2019-2025)
• 11.2 Global Immune Thrombocytopenic Purpura Therapeutics Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Immune Thrombocytopenic Purpura Therapeutics Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Immune Thrombocytopenic Purpura Therapeutics Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Immune Thrombocytopenic Purpura Therapeutics Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Immune Thrombocytopenic Purpura Therapeutics Production, Revenue Forecast (2019-2025)
• 11.3 Global Immune Thrombocytopenic Purpura Therapeutics Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Immune Thrombocytopenic Purpura Therapeutics Consumption Forecast (2019-2025)
  • 11.3.2 Europe Immune Thrombocytopenic Purpura Therapeutics Consumption Forecast (2019-2025)
  • 11.3.3 China Immune Thrombocytopenic Purpura Therapeutics Consumption Forecast (2019-2025)
  • 11.3.4 Japan Immune Thrombocytopenic Purpura Therapeutics Consumption Forecast (2019-2025)
• 11.4 Global Immune Thrombocytopenic Purpura Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Immune Thrombocytopenic Purpura Therapeutics Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List